Blood Cloth
Birth control pills often make problem to women like Bayer’s Yas and Yasmin because of concerns that they may raise woman’s risk of blood cloth. The agency cities two studies, published in April in BMJ, found that women aged 15-44 taking drospirenone-containing birth control pills were two to three times more likely to develop venous thromboembolism. The blood cloth that happen to the deep vein of the women leg, because of consume this pills usually contain progestrin levonorgestrel.
This research finding make the European regulators said last week that they would revise prescribing information for relevant product to include the new findings. FDA (Federation Drug Agency) evaluate the conflict result from these studies and will took at all currently available information to fully assess the risks and benefits of drospirenone-containing birth control pills. To make sure this research result make agreement with FDA and with attorneys general of 27 states, the company agreed to spend $ 20 million on a new campaign clearing up the confusing and more explicitly stating the true benefits and risks of the medication.
Until now, the FDA is not recommending that women taking drospirenone-containing medications stop using them without consulting their doctor. So women that consume this drug should alert to the symptoms of blood clots, including persistent leg pain, severe chest pain, or sudden shortness of breath, and contact their doctors if symptoms occur.
This research finding make the European regulators said last week that they would revise prescribing information for relevant product to include the new findings. FDA (Federation Drug Agency) evaluate the conflict result from these studies and will took at all currently available information to fully assess the risks and benefits of drospirenone-containing birth control pills. To make sure this research result make agreement with FDA and with attorneys general of 27 states, the company agreed to spend $ 20 million on a new campaign clearing up the confusing and more explicitly stating the true benefits and risks of the medication.
Until now, the FDA is not recommending that women taking drospirenone-containing medications stop using them without consulting their doctor. So women that consume this drug should alert to the symptoms of blood clots, including persistent leg pain, severe chest pain, or sudden shortness of breath, and contact their doctors if symptoms occur.
<< Home